Clinical trial
HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers
NCT00102089 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00102089 |
|---|---|
| Title | HIV-1 Vaccine Booster in Previously Immunized Uninfected Adult Volunteers |
| Official title | A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of a Booster Dose of a Recombinant Multiclade HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Subjects Who Were Previously Immunized With VRC-HIVDNA009-00-VP in VRC 004 |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, HIV Infections |
| Intervention type | Biological, Drug |
| Interventions | VRC-HIVADV014-00-VP booster, VRC-HIVADV014-00-VP |
| Enrollment | 32 |
| Start date | Jan 18, 2005 |
| Completion | Oct 10, 2007 |
| First posted | Jan 21, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: